A second-generation eIF4A RNA helicase inhibitor exploits translational reprogramming as a vulnerability in triple-negative breast cancer
第二代 eIF4A RNA 解旋酶抑制剂利用翻译重编程作为三阴性乳腺癌的弱点
期刊:Proceedings of the National Academy of Sciences of the United States of America
影响因子:9.1
doi:10.1073/pnas.2318093121
Cencic, Regina; Im, Young K; Naineni, Sai Kiran; Moustafa-Kamal, Mohamed; Jovanovic, Predrag; Sabourin, Valerie; Annis, Matthew G; Robert, Francis; Schmeing, T Martin; Koromilas, Antonis; Paquet, Marilène; Teodoro, Jose G; Huang, Sidong; Siegel, Peter M; Topisirovic, Ivan; Ursini-Siegel, Josie; Pelletier, Jerry
